Trial Profile
A phase I proof-of-concept study of AEZS 120 in prostate cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 04 Aug 2015
Price :
$35
*
At a glance
- Drugs AEZS 120 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 04 Aug 2015 New trial record